Lazard Asset Management LLC Generation Bio Co. Transaction History

Lazard Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.91 - $3.35 $170 - $626	-187 Reduced 5.76%	3,061 $5,000
Q3 2023 Nov 14, 2023	BUY	$3.65 - $6.9 $598 - $1,131	164 Added 5.32%	3,248 $12,000
Q2 2023 Aug 14, 2023	BUY	$3.5 - $5.67 $427 - $691	122 Added 4.12%	3,084 $16,000
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $2,126 - $4,128	589 Added 24.82%	2,962 $12,000
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $8,685 - $16,065	2,373 New	2,373 $9,000

52.7M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $40.1M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.